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Abstract
Background: C-type lectin (CLEC) receptors are important for initiating and shaping immune responses; however,
their role in inflammatory reactions in the central nervous system after traumatic injuries is not known. The antigen-
presenting lectin-like receptor gene complex (Aplec) contains a few CLEC genes, which differ genetically among
inbred rat strains. It was originally thought to be a region that regulates susceptibility to autoimmune arthritis,
autoimmune neuroinflammation and infection.
Methods: The inbred rat strains DA and PVG differ substantially in degree of spinal cord motor neuron death
following ventral root avulsion (VRA), which is a reproducible model of localized nerve root injury. A large F2
(DAxPVG) intercross was bred and genotyped after which global expressional profiling was performed on spinal
cords from F2 rats subjected to VRA. A congenic strain, Aplec, created by transferring a small PVG segment
containing only seven genes, all C-type lectins, ontoDA background, was used for further experiments together
with the parental strains.
Results: Global expressional profiling of F2 (DAxPVG) spinal cords after VRA and genome-wide eQTL mapping
identified a strong cis-regulated difference in the expression of Clec4a3 (Dcir3), a C-type lectin gene that is a part of
the Aplec cluster. Second, we demonstrate significantly improved motor neuron survival and also increased T-cell
infiltration into the spinal cord of congenic rats carrying Aplec from PVG on DA background compared to the
parental DA strain. In vitro studies demonstrate that the Aplec genes are expressed on microglia and upregulated
upon inflammatory stimuli. However, there were no differences in expression of general microglial activation
markers between Aplec and parental DA rats, suggesting that the Aplec genes are involved in the signaling events
rather than the primary activation of microglia occurring upon nerve root injury.
Conclusions: In summary, we demonstrate that a genetic variation in Aplec occurring among inbred strains
regulates both survival of axotomized motor neurons and the degree of lymphocyte infiltration. These results
demonstrate a hitherto unknown role for CLECs for intercellular communication that occurs after damage to the
nervous system, which is relevant for neuronal survival.
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Introduction
Both innate and adaptive immune responses, involving
local as well as blood-derived immune cells, have been
shown to exert both protective and detrimental effects
after traumatic nerve injuries, but there is still limited
knowledge on how this regulation is executed.
Probably the most studied immune cells, with regard
to traumatically induced immune responses, are the
microglia [1], which are a versatile and heterogeneous
cell population. Microglia also constitute the main
antigen-presenting cells of the central nervous system
(CNS) [2], and are as such key players in eliciting subse-
quent immune responses, which include recruitment of
immune cells both from the innate and adaptive im-
mune compartments.
Innate immune cells, like neutrophils [3], monocytes
and macrophages [4], infiltrate the CNS after acute in-
juries. Whereas neutrophils have mostly been linked to
unfavorable consequences [5], monocytes and macro-
phages have been associated both with protection and
exaggeration of injury [6,7]. Regarding the role of cells
from the adaptive immune system following traumatic
CNS injuries, both T and B cells have been shown to
confer both protective and deleterious effects [8-10].
These partly discordant results likely depend on the
complex interplay between the differentcelltypes and the
milieu, which in turn may differ depending on genetic
background. An interesting example of the synergy
between immune cells in the CNS was recently demon-
strated in a mouse model of amyotrophic lateral scler-
osis (ALS), where T cells in concert with microglia were
shown to provide significant protection from motor
neuron loss [11]. In this model, upregulation of CD69
on CD3+ T cells and an altered microglia phenotype
with upregulated expression of dendritic cell (DC)
receptors conferred the observed protection [11]. CD69,
also known as Clec2c, is commonly used as an early
marker of T-cell activation [12] and is a C-type lectin
(CLEC) receptor, believed to be important in modifying
immune responses, for example by downregulating det-
rimental Th17 responses [13].
CLECs are otherwise mostly studied in the context of
dendritic cells and are thought to be involved in initiat-
ing and shaping immune responses [14]. The CLEC fam-
ily includes a large number of molecules, most of which
have unknown binding partners and functional roles,
but are nevertheless thought to be important for innate
immune reactions [15,16]. Structurally, the CLECs dis-
play certain similarities to some of the complement pro-
teins [17], which on the other hand are well established
as involved in neuroimmune responses [18].
On rat chromosome 4 (mouse chromosome 6 and hu-
man 12), a set of CLECs is grouped together and forms
a gene cluster called the antigen-presenting lectin-like
receptor gene complex (Aplec). A naturally occurring
variability in the Aplec cluster was originally positioned
to regulate susceptibility to experimental autoimmune
arthritis in rats [19]. Subsequent studies using a congenic
strain with Aplec from the PVG rat ontoDA background
demonstrated regulatory influence of this region for
susceptibility to experimental allergic encephalomyelitis
(EAE) (unpublished data) as well as the response of
macrophages to infectious stimuli [20]. In humans, the
corresponding region shows a suggestive association with
rheumatoid arthritis [21-23]. Taken together these obser-
vations suggest this gene cluster is of importance for regu-
lating immune responses involving both the adaptive and
innate arms of the immune system. However, the exact
molecular pathways for the disease regulatory effect are
still unknown and the C-type lectins have so far not been
studied in the context of traumatic nerve injuries.
The inbred rat strains DA and PVG differ substantially
in degree of spinal cord motor neuron death following
ventral root avulsion (VRA), which is a reproducible
model of localized nerve root injury that induces cell
death and localized inflammation in the spinal cord. An
unbiased global expression profiling study in a large F2
(DAxPVG) intercross subjected to VRA revealed strong
differences in expression of a gene in the Aplec cluster.
Subsequent experiments with congenic Aplec rats dem-
onstrated a significantly improved survival of avulsed
motor neurons, which was associated with increased
T-cell infiltration, compared to the parental DA strain.
These observations suggest that the Aplec region is im-
portant for inflammatory activation occurring after nerve
root injury, which is relevant for nerve cell survival.
Materials and methods
Animals and surgery
All animal experiments were approved by the local animal
ethics committee, Stockholms Norra Djurförsöksetiska
Nämnd, under the ethical permit numbers N122/11 and
N478/12.
The DA.RT1av1, hereafter called DA, strain was origin-
ally obtained from Professor Hans Hedrich (Medizinische
Hochschule, Hannover, Germany), whilst the PVG.RT1av1
strain, hereafter called PVG, is a major histocompatibility
complex (MHC) congenic strain originating from Harlan
UK Ltd (Blackthorn, UK). Both are kept as breeding
colonies at our in-house animal facility. The Aplec strain,
generously provided by Dr Jian Ping Guo, was created by
repeated backcrossing of DAxPVG F1 animals onto DA
background as previously described [19,22,24]. The
congenic PVG insert spans from 159.46 to 159.98 Mb on
chromosome 4. It contains six characterized genes and
one uncharacterized gene, all C-type lectins, according to
the latest version of the Ensembl database [25]. Animals
were bred under pathogen-free and climate-controlled
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conditions with 12 h light/dark cycles. They were housed
in polystyrene cages with wood shavings and provided
with a standard rodent diet and water ad libitum. The F2
(DAxPVG) intercross used for expressional profiling has
been previously described [26]: in brief breeding couples
composed of either a DA male and PVG female, or a DA
female and a PVG male were used to generate two groups
of offspring (F1), which were subsequently mated recipro-
cally, to generate four groups of F2 progeny. A total of
144 F2 animals, equal numbers from all four groups with
both female and male rats were included.
All animals except for naïve controls were subjected to
a unilateral avulsion of the left L3-L5 ventral roots at an
age of 9 to 10 weeks. This procedure was done under
deep isoflurane anesthesia. In brief, a dorsal laminec-
tomy was performed at the level of the L2-L3 vertebrae.
The dura was carefully opened with the point of a nee-
dle. By gently moving the sensory nerve roots, the L3-L5
ventral roots could be identified and avulsed from the
spinal cord using a micro-forceps. The muscles and skin
were then closed in layers and the animals were allowed
to recover. Post-operative analgesia (buprenorphine, 0.1
ml, 0.3 mg/ml, RB Pharmaceuticals, Slough, UK) was
given subcutaneously twice daily. Five- or 21-day post-
operative survival was used throughout. Eight DA and
eight Aplec rats were used in the neuronal count experi-
ment. Nine DA and nine Aplec rats were used in the
microarray studies. Five DA, five PVG and five Aplec
rats were used for flow cytometry experiments. All ani-
mals were euthanized with CO2 and perfused via the as-
cending aorta with 200 ml PBS containing heparin 10
IE/ml (Leo Pharma AB, Malmö, Sweden) to ensure re-
moval of as much blood as possible from tissues. All
spinal cords were examined in a dissection microscope
to verify completeness of the avulsion injury at the cor-
rect three levels and animals with incomplete lesions
were excluded from the study; for this reason six F2 ani-
mals, one DA and one Aplec, both from the neuronal
count experiments, were excluded. For the RT-PCR ex-
periments, the ipsilateral ventral quadrant of the L3 seg-
ment was dissected, with careful removal of the scar on
the ventral surface of the spinal cord, snap frozen and
stored at −70°C. The L4 and L5 cord was dissected en
bloc and stored at −70°C until cryostat sectioning. For
the flow cytometry experiments the ipsilateral side of the
L3-5 segments was taken en bloc for further processing.
Myelin oligodendrocyte glycoprotein immunization and
T-cell sorting from lymph nodes
Five DA and five Aplec female rats, 8 to 10 week old,
were immunized using recombinant myelin oligodendro-
cyte glycoprotein (rMOG), aa 1–125, from the N-
terminus, which was first expressed in Escherichia coli
and purified to homogeneity by chelate chromatography,
as previously described [27]. The purified protein,
dissolved in 6 M urea, was dialyzed against PBS. The
rats were anesthetized with isofluorane (Forene, Abbott
Laboratories, Abbot Park, IL) and immunized with a sin-
gle subcutaneous injection at the dorsal tail base with
200 μl of inoculum containing rMOG (12.5 μg/rat) in sa-
line emulsified in a 1:1 ratio with incomplete Freund’s
adjuvant (IFA) (Sigma Aldrich, St. Louis, MO). At 7 days
after immunization, before clinical EAE had developed,
animals were euthanized using CO2. Draining inguinal
lymph nodes were collected from the ten immunized
rats, and also ten naïve animals, five DA and five Aplec
females. The lymph nodes were placed in DMEM
(Gibco-BRL, Grand Island, NY), enriched with 10% fetal
calf serum, 1% L-glutamine, 1% penicillin-streptomycin
and 1% pyruvic acid (all from Life Technologies, Paisley,
UK) before being mechanically separated by passing
through a mesh screen with the bolus of a syringe. Cells
were stained for 30 min at 4°C with CD3, CD45RA and
RT1B antibodies (all from BD Biosciences, San Jose, CA,
USA), and sorted with a MoFlo cell sorter (Beckman-
Coulter, Brea, CA). After sorting, total RNA was isolated
from the T-cell subset using a standard protocol (see
below, RT-PCR section) before being converted into
cDNA (also below).
RT-PCR
Spinal cord samples were dissociated in Lysing Matrix D
tubes (MP Biomedicals, Irvine, CA) on a FastPrep
homogenizer (MP Biomedicals, Solon, OH) and resus-
pended in RLT buffer (Qiagen, Hilden, Germany) for
total RNA preparation. Cells (T cells and glia) were
lysed directly in the RLT buffer. Total RNA was
extracted, purified and on column DNase I treated using
an RNeasy Mini kit (Qiagen) and RNase-Free DNase Set
(Qiagen), according to the manufacturers’ protocols.
RNA from the L3 segments was further processed for
cDNA preparation as described below, and RNA from
the L4 segments was taken for array hybridization, as
described below. All steps were performed under
RNase-free conditions. Real-time PCR was conducted
using a three-step PCR protocol using IQ5 or the Bio-
Rad CFX 384 SYBR green optical system (Bio-Rad,
Hercules, CA). All primers and probes were designed
with Beacon Designer 5.0 software (Bio-Rad), and tested
for specificity by running the amplified product on gels
with silver staining. Two house-keeping genes were
used to normalize the levels of mRNA expression of
the studied transcripts; hypoxanthine guanine phos-
phoribosyl transferase (HPRT) and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and normalized
expression levels were calculated with the IQ5 software
or the Bio-Rad CFX manager v1.6 (Bio-Rad). For primer
sequences see Table 1.
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Microarray expressional profiling
RNA from the L4 spinal cord segment from five naïve
DA and five naïve Aplec rats, as well as from four DA
and four Aplec rats 5 days post-VRA operation, was
sampled for global expressional profiling. The micro-
array analysis was performed at the Bioinformatics and
Expression Analysis Core Facility (BEA) facility of the
Karolinska Institute using Affymetrix Rat gene 1.0 ST
Array chips (Affymetrix, Santa Clara, CA). In the first-
round synthesis of double-stranded cDNA, 100 ng of
total RNA was used. RNA was reverse transcribed using
a whole transcript cDNA synthesis and amplification kit
(Affymetrix UK Ltd, High Wycombe, UK). The resulting
biotin-labeled cRNA was purified using an in vitro tran-
scription (IVT) clean-up kit (Affymetrix) and quantified
using a NanoDrop ND-1000 Spectrophotometer (A260/
280; NanoDrop Technologies, Wilmington, DE). An
aliquot (5.5 μg) of cRNA was fragmented by heat and
ion-mediated hydrolysis at 94°C for 35 min. Confirm-
ation of RNA quality was assessed using the Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA). Target labeling, and array hybridization, washing
and staining were performed as described in the
GeneChip Whole Transcript (WT) Sense Target Label-
ling manual [28]. Arrays were scanned using the
GeneChip Scanner 3000 7G and the GeneChip Com-
mand Console (Affymetrix) with default set-up. For each
sample, 2 μg of total RNA was used. Probe details can
be found on the Affymetrix website [28]. The microarray
data is available in Minimal Information About a
Microarray Experiment (MIAME) compliant format at
the ArrayExpress Database [29] under accession code
E-MTAB-920. The expression data was imported into
the software Partek Express (Partek Incorporated, St
Louis, MO), where it is normalized using the RMA algo-
rithm [30]. On the Rat gene ST 1.0, array genes are rep-
resented by multiple probe sets. Affymetrix assigns these
probe sets to transcript clusters. Briefly, raw expression
intensities are background corrected, quantile normal-
ized, log2 transformed and summarized at a probe set
level. The resulting normalized data was then filtered
using the following criteria; first all genes significantly
differing in expression between the operated DA and
Aplec rats were selected (P < 0.01 was chosen as the
cut-off ). Second, the identified genes were checked to
see if they were different between naïve Aplec and oper-
ated Aplec rats, with P < 0.01, which they all were, to
ensure that the identified genes shown to differ in in-
jured DA and Aplec rats indeed were injury related and
not already different in the naïve state. The resulting
gene list was then imported into the DAVID database to
investigate for potential pathway enrichment [31,32].
Expression quantitative trait loci (eQTL) mapping in the
F2 (DAxPVG) intercross
The main analysis of the microarray data from the F2
intercross will be published separately (unpublished
data), but the expression data is available in MIAME-
compliant format at the ArrayExpress Database [29],
accession code E-MTAB-303. Raw expression intensities
were background corrected, normalized, log2 transformed
and summarized on a probe set level as above but then in-
stead implemented in the Bioconductor package oligo.
Average expression values of all probe sets annotated to a
Table 1 Sequences of primers used for RT-PCR
















RT-PCR: real-time polymerase chain reaction.
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transcript cluster were used to measure expression on the
level of a gene based on annotation from Bioconductor
package pd.ragene.1.0.st.v1.
The genotyping of the F2 intercross has been previ-
ously described (unpublished and [26]). Briefly, genomic
DNA was extracted from rat tail tips according to a
standard protocol [33]. Polymorphic microsatellite markers
were selected from the Rat Genome Database [34] and the
Ensembl database [25]. The F2 intercross was genotyped
with 113 microsatellite markers evenly distributed across
the genome, with an average distance of 20 cM based on
previous knowledge of optimum spacing [35]. The success-
ful genotyping rate was 95.3%. Subsequently, we mapped
eQTLs for all transcript clusters using the QTL reaper
software [36] against the 113 genomic markers. In order
to assess the genome-wide significance of eQTLs we
performed 106 permutations: P < 0.01 at a genome-wide
level was considered significant. We classified eQTLs into
cis- or trans-acting according to the distance between the
locations of genetic marker and the affected transcript. If
the distance was smaller than 20 Mb we assumed cis- and
otherwise trans-regulation.
Flow cytometry
The L3-5 segments of the ipsilateral side of the spinal
cords sampled at 5 days after VRA were homogenized in
4 ml 50% Percoll solution (Sigma-Aldrich, St Louis,
USA) and transferred to a sterile 15 ml Falcon tube
(Sarstedt, Nümbrech, Germany). A density gradient was
made by carefully adding a bottom layer of 3 ml 63%
Percoll solution (Sigma) under the middle layer with the
cell suspension in 50% Percoll and finally adding a top
layer of 30% Percoll. All Percoll solutions were made by
diluting adding Percoll in 1xHBSS (Hank’s balanced salt
solution) (Invitrogen, Sweden) and adding 0.1% glucose
and 0.1% BSA. After centrifugation at 1000g at 4°C for
30 min without a break, the cells were collected, washed
at 600 g at 10°C for 15 min with PBS containing 5% FCS
and 0.01% tris-EDTA (Tris(hydroxymethyl)aminomethane
(Tris)- Ethylenediaminetetraacetic acid (EDTA)), stained
and resuspended in 100 μl of PBS with 0.01% tris-EDTA
for flow cytometry. Cells were stained for 20 min at 4°C
using the antibodies CD3-APC and CD11b-FITC (both
from BD Biosciences, San Jose, CA), then washed in PBS
before staining. They were visualized on a Gallios flow
cytometer (Beckman-Coulter) with Gallios software and
analyzed using Kaluza v.1.0 (both Beckman-Coulter).
The cells from each sample were acquired under a
constant speed, but with acquisition times that varied
between the samples because of small differences in cell
density, with the acquisition stopping when a fixed num-
ber of cells (10,000) were counted. In order to normalize
the samples and get a more representative number of
the total number of cells per gate per sample, the
number of cells per each specific gate was divided by the
acquisition time for that specific sample, and presented
as the number of cells per 100 seconds.
Nerve cell counts
Serial transverse frozen sections (14 μm) of tissue from
blocks containing the spinal cord L4-5 segments from
DA and Aplec animals 21 days post-VRA were cut in a
cryostat, starting from the mid L5 segment and serially
cutting towards the rostral end of the L4 segment. The
spinal cords were mixed randomly in each block used
for consecutive sectioning and mounting on tissue slides.
Nerve cell counts of cresyl violet counterstained sections
were performed as described previously [37,38]. In brief,
motor neurons with a visible nucleus were counted by a
single, blinded observer. Every fifth spinal cord section,
with a total of 25 sections from each rat, was counted.
Each slide contained sections mounted in a similar fash-
ion in order to reduce the risk of bias. Shrinkage of cell
bodies of axotomized nerve cells occurs following VRA;
however, we have previously found that the degree of
shrinkage does not differ in a panel of inbred strains that
included DA and PVG [38]. No correction for cell shrink-
age was performed here as this would not affect the rela-
tive difference in nerve cell survival between the two
strains. The degree of neurodegeneration is presented as a
ratio of the total number of motor neurons on lesioned
and unlesioned sides, respectively, in each rat.
Immunohistochemistry
Spinal cord sections were serially cut (14 μm) on a cryo-
stat (Leica Microsystems, Wetzlar, Germany) at the level
of the L4 segment, thawed onto Superfrost plus micro-
scope slides (Menzel-Gläser, Braunschweig, Germany)
and stored at −20°C until further processing for immu-
nohistochemistry. Sections were post-fixed in RT 4% for-
maldehyde (Iba1) for 30 min or ice-cold acetone (Gfap)
for 10 min, rinsed in PBS and incubated overnight at 4°C
with primary antisera directed against Gfap (rabbit anti-
human, 1:200, Dako, Stockholm, Sweden) or Iba1 (rabbit
anti-rat, 1:200, Wako, Richmond, VA), then rinsed in PBS,
incubated for 60 min with an appropriate fluorophore-
conjugated secondary antibody (Alexa Fluor 594 donkey-
anti-rabbit, 1:150 and Alexa Fluor 488, goat anti-rabbit,
1:300, both from Invitrogen), diluted in PBS and 0.3%
Triton X-100, then rinsed in PBS and mounted in PBS-
glycerol (1:3). Sections processed for immunohistochemis-
try were examined and captured in a Leica DM RBE
microscope system (Leica).
Astrocyte and microglia cultures
Primary astrocytes and microglia were isolated from
adult DA and PVG brains of 10-week-old rats perfused
via the ascending aorta with ice-cold PBS containing
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heparin. After removing the meninges and the cerebel-
lum, the brains were homogenized in enzymatic solution
(116 mM NaCl, 5.4 mM KCl, 26 mM NaHCO3, 1 mM
NaH2PO4, 1.5 mM CaCl2, 1 mM MgSO4, 0.5 mM EDTA,
25 mM glucose, 1 mM cysteine and 20 u/ml papain – all
from Sigma) using a micro-scissor. The homogenate was
incubated for 60 min with gentle stirring at 37°C, 5% CO2.
Next, the digested tissue was transferred to a 50 ml con-
ical tube. The enzymatic reaction was stopped by adding
HBSS (Invitrogen, Sweden) with 20% FCS. The homogen-
ate was spun down at 200 g for 7 min and the pellet
resuspended in 2 ml of 0.5 mg/ml DNaseI (Roche,
Sweden) in HBSS, then filtered through a 40 μm strainer
(Becton Dickinson, Sweden) and transferred to 20 ml of
20% stock isotonic Percoll in HBSS. Another 20 ml pure
HBSS was carefully added on top to create a Percoll
gradient; the samples were then gently centrifuged at
200 g for 20 min. The resulting pellet was washed once in
HBSS and the cells resuspended in DMEM/F12 complete
medium, supplemented with 10% heat-inactivated FCS,
penicillin-streptomycin (100 u/ml, 100 μg/ml), 2 mM L-
glutamine (Life Technologies) and 30% M-CSF condi-
tioned L929 cell line supernatant. The cells were
then plated in 75cc tissue flasks (Sarstedt, Nümbrecht,
Germany) coated with poly-l-lysine (Sigma) and incubated
at 37°C and 5% CO2 in a humidified incubator. The
medium was changed twice weekly until the cells
became confluent (approximately 14 days). When full
confluence of the cell layer was reached, the mixed glial
cells were harvested using pre-warmed trypsin (Gibco).
To separate microglia and astrocytes from each other
in the mixed glial cell culture, magnetic separation was
used according to the manufacturer’s instructions. In
brief, the mixed cell suspension was centrifuged at 300g
for 10 min. The cell pellet was resuspended in MACS
buffer (Miltenyi Biotec GmbH, Germany) and stained
with mouse anti-rat CD11b-PE (BD Biosciences, Sweden)
for 10 min. Then, the cells were washed and resuspended
in MACS buffer followed by AutoMACS magnetic separ-
ation using anti-PE MicroBeads (Miltenyi). The resulting
microglia (CD11+ cells) and remaining cells (astrocytes)
were seeded in 24-well plates (4 × 105 cells/well and 2 ×
105 cells/well, respectively).
The cells (microglia and astrocytes) were then left
unstimulated (only DMEM/F12 complete medium, sup-
plemented with 10% heat-inactivated FCS, penicillin-
streptomycin 100 u/ml, 100 μg/ml), or stimulated with
recombinant rat TNF-α (R&D Systems, Minneapolis,
MN) at 20 ng/ml (in the same medium) for 24 h after
which the cells were lysed for RNA extraction and sub-
sequent RT-PCR expressional analysis. The purities of
microglia and astrocytes were checked with flow cytom-
etry as described above using PE-labeled mouse anti-
rat CD11b and FITC labeled mouse anti-rat GFAP
antibodies (both from BD Pharmingen, Franklin Lakes,
NJ). The purities of microglia and astrocytes were above
95% (data not shown).
Statistical analysis
Partek uses ANOVA to test for expression differences
with P < 0.01 chosen as the cut-off. In the studies of motor
neuron survival, significance levels between two strains
were calculated using the unpaired t-test (GraphPad Prism
5.0; San Diego, CA). In RT-PCR studies of multiple
groups, one-way ANOVA with the Bonferroni post hoc
test was used (GraphPad) to measure differences in
mRNA expression as well as in the microarray expression
studies. In the sorted T-cell studies, the unpaired t-test
was used. In general P < 0.05 was considered statistically
significant.
Results
Clec4a3 is differentially regulated following ventral root
avulsion
The inbred rat strains DA and PVG differ substantially
in degree of nerve cell death following VRA, with almost
a twofold increased survival in the PVG strain compared
to DA [26,38]. Since early reactions following injury
likely affect downstream events, such as nerve cell death,
we set up an F2 (DAxPVG) intercross and performed
global transcriptional profiling of injured spinal cords
combined with whole-genome linkage analysis to define
eQTLs. Multiple eQTLs were identified and they will be
presented separately (unpublished results). Interestingly,
one of the strongest regulated eQTLs in the whole data
set was Clec4a3, also called Dcir3, a C-type lectin recep-
tor (Figure 1A-B), which does not have a defined role in
the CNS (Table 2). Expression of Clec4a3 was higher in
animals carrying PVG alleles at the peak marker
D4Got130 (Figure 1C). MHCII-related genes [39] and
glutathione-related genes [26] were also found to be
highly differentially regulated between DA and PVG rats
and have been reported previously.
C-type lectins regulate motor neuron survival following
VRA
Given a strong genetic influence on the expression of
Clec4a3 and co-regulation of the expression of multiple
C-type lectins with complement proteins such as C1q
(unpublished results), which in turn is associated with
degeneration of motor neurons following VRA [40], we
set out to explore if genetic differences in C-type lectins
also affect motor neuron survival. DA and congenic
Aplec rats (containing a small PVG insert on a DA back-
ground with seven functional genes, all C-type lectins)
were operated with unilateral VRA and allowed to sur-
vive for 21 days after which motor neuron survival on
the injured side was assessed. DA rats had an average
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Figure 1 (See legend on next page.)
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motor neuron survival of 26%, in line with previous
studies [26,37], whereas Aplec rats displayed a signifi-
cantly increased motor neuron survival, with an average
survival of 35% (P < 0.05; Figure 1D-H). The PVG strain
has previously been demonstrated to have a motor
neuron survival of 40% [26].
Expressional profiling of DA and Aplec rats reveals
differences in inflammatory pathways and T-cell
activation
To explore early post-injury processes that differ be-
tween DA and Aplec rats, we performed a microarray
scan of the gene expression profiles in L4 spinal cord
(See figure on previous page.)
Figure 1 Clec4a3 is cis-regulated after nerve root injury and the Aplec complex confers neuroprotection. The inbred DA and PVG rat
strains display considerable, genetically determined, differences in spinal cord motor neuron survival following VRA. Global expressional profiling
of lesioned spinal cord ventral horn tissue from an F2 (DAxPVG) intercross reveals several strong eQTLs. One of the strongest eQTLs among more
than 27,000 transcripts is Clec4a3, a C-type lectin with hitherto unknown function in the CNS. Clec4a3 was cis-regulated from chromosome 4 (A)
from marker D4Got130 (B). All F2 animals were genotyped over the whole genome and the PVG genotype in marker D4Got130 was found to
lead to higher expression of Clec4a3 (C), with highest expression in PVG homozygotes; the heterozygotes displayed an intermediate phenotype.
The Aplec congenic strain, which has a small fragment from PVG onto DA background containing six characterized C-type lectin genes including
Clec4a3, displays significantly improved motor neuron survival compared to DA at 21 days after VRA (D). A representative section from the L4
segment shows motor neurons in the ventral horn on the contralateral (CL) and ipsilateral (IL) sides of the cord (axotomized cells are indicated
by arrows) in one Aplec (E and G) and one DA (F and H) rat. In A the x-axis marks each chromosome and in B it is the genetic distance on
chromosome 4 measured in centimorgans (cM); the y-axis shows the logarithm of odds (LOD)-score, where LOD > 3.1 corresponds to a genome
wide P < 0.001, and the current LOD-score of around 20 to P = 0. The scale bar in the micrographs corresponds to 80 μm. Aplec: antigen-
presenting lectin-like receptor gene complex; CL: contralateral; CNS: central nervous system; eQTL: expression quantitative trait loci; IL: ipsilateral;
LOD: logarithm of odds; VRA: ventral root avulsion.
Table 2 The 20 strongest regulated eQTLs in the F2(DAxPVG) intercross
Transcript ID Gene symbol Gene name Locus Chr cM LOD score P Value
10926967 LOC501110 Similar to glutathione S-transferase A1 (GTH1) (HA
subunit 1) (GST-epsilon) (GSTA1-1)
D9Rat130 9 57 65.6988845987 0
10824140 Msr2_predicted Macrophage scavenger receptor 2 (predicted) D2Rat44 2 15 55.6575859002 0
10877130 Ltb4dh Leukotriene B4 12-hydroxydehydrogenase D5Rat77 5 36 39.6332668113 0
10908861 Ldha Lactate dehydrogenase A D1Rat265 1 2 38.7544785249 0
10802013 Cd74 CD74 antigen (invariant polypeptide of major
histocompatibility complex, class II antigen-
associated)
D10Mgh25 10 62 37.3794915401 0
10711664 Acadsb Acyl-Coenzyme A dehydrogenase, short/branched
chain
D1Arb21 1 7 35.2231095445 0
10828344 RT1-Da RT1 class II, locus Da D10Mgh25 10 62 32.6411125813 0
10831567 RT1-Bb RT1 class II, locus Bb D10Mgh25 10 62 31.6910114967 0
10784621 Ephx2 Epoxide hydrolase 2, cytoplasmic D15Rat123 15 87 30.8274874187 0
10714907 Ifit1 Interferon-induced protein with tetratricopeptide
repeats 1
D1Rat301 1 9 27.9442878525 0
10829888 Pbld Phenazine biosynthesis-like protein domain
containing
D20Rat7 20 107 25.4372427332 0
10725724 Eif3c Eukaryotic translation initiation factor 3, subunit C D1Arb21 1 7 25.4264147505 0
10812515 Arsb Arylsulfatase B D2Rat3 2 12 23.7304626898 0
10725778 Nupr1 Nuclear protein 1 D1Arb21 1 7 23.4051659436 0
10866041 Klrk1 Killer cell lectin-like receptor subfamily K, member 1 D4Got130 4 31 21.7980872017 0
10825931 MGC108896 Similar to glutathione transferase GSTM7-7 D2Rat44 2 15 21.7509939262 0
10725846 Ccdc95 Coiled-coil domain containing 95 D1Arb21 1 7 21.0341839479 0
10856673 Slc4a5 Solute carrier family 4, sodium bicarbonate
cotransporter, member 5
D4Rat177 4 29 20.8720767896 0
10858559 Clec4a3 C-type lectin domain family 4, member a3 (Dcir3) D4Got130 4 31 20.3859516269 0
10916458 RGD1309108_predicted Similar to hypothetical protein FLJ23554 (predicted) D8Rat41 8 50 20.0893368764 0
eQTL: expression quantitative trait loci.
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segments at 5 days after VRA, that is, the same time
point used in the study of the F2 rats. Analysis of the
global expressional profiling data showed 229 transcripts
that differed between Aplec and DA rats at P < 0.01. All
these transcripts were found also to differ between naïve
DA and Aplec rats, indicating that they were part both
of a strain and injury response (Additional file 1: Table
S1). Clec4a3, one of the seven Aplec genes, was the tran-
script differing most between operated DA and Aplec
rats and the second most differing transcript between
naïve and operated Aplec rats. The identified genes were
clustered for pathway enrichment using the DAVID
functional annotation tool [31,32]. As expected, many
clusters involved metabolic, neurodevelopmental and in-
flammatory processes. Also not surprisingly, the cluster
with the highest enrichment score contained several of
the genes in the Aplec complex, and was enriched for
carbohydrate binding (P = 0.016) and C-type lectins (P =
0.022). The cluster included the genes Clec4a3 (Dcir3),
Clec4a2 (Dcir2) and Clecsf6 (Dcir1), which are all in-
cluded in the Aplec region, but also Cd69 (Clec2c)
(Table 3). Apart from being a C-type lectin, CD69 is also
a marker of activated T cells [12].
Of the seven genes in the Aplec complex Clec4a1
(Dcir4), Clec4a2, Clec4a3 and Clecsf6 were upregulated
following injury in both strains, but with a higher ex-
pression of Clec4a3 and Clec4a2 in Aplec rats and of
Clecsf6 in DA rats. Clec4b2 (Dcar1), Clec4d (Mcl) and
Clec4e (Mincle) were not significantly regulated, either
by VRA or by strain (Figure 2A-G). Cd69, which does
not physically locate to the Aplec complex, was
upregulated by VRA only in the Aplec strain (Figure 2H).
Replication with RT-PCR was performed on L3 seg-
ments from the same animals as used in the microarray
study to confirm the expression of most of the above
mentioned genes, except for Mincle and Mcl, which
were lowly expressed and without differences between
strains. The RT-PCR expression showed similar results
as the microarray (Additional file 2: Figure S1).
Increased Cd69 expression likely reflects an increased
number of T cells
Increased Cd69 expression after VRA, seen in Aplec but
not DA rats, indicated potential involvement of T cells
in the injury response. As quantification of Cd69 expres-
sion cannot distinguish differences in cellular compos-
ition, that is, infiltration of cells, from a relative increase
in expression across cells, we characterized T cells from
both strains regarding Cd69 expression. MOG immu-
nization was performed in DA and Aplec rats, and T
cells were sorted from inguinal lymph nodes 7 days after
immunization, before clinical EAE developed. T cells
were also sorted from inguinal lymph nodes of naïve ani-
mals from both strains. Cd69 expression in the T cells
was subsequently analyzed with RT-PCR. There was no
difference in Cd69 expression between Aplec and DA T
cells, neither in the naïve nor the immunized state
(Figure 2I,J). Cd4 and Cd8 expression was also identical
between strains (data not shown). This suggests that the
increased Cd69 expression in the spinal cord of Aplec
rats compared to DA rats comes from an increase in the
number of T cells, rather than a differential regulation of
Cd69 expression per se.
T-cell infiltration differs between Aplec, PVG and DA rats
following VRA
To further confirm the strain differences regarding T
cells, DA, PVG and Aplec rats were subjected to VRA
and spinal cord tissue was collected at 5 days after injury
for flow cytometry. PVG rats were included for com-
parative purposes as this phenotype has not previously
been determined in this strain. However, in a previous
study infiltration of CD3+ cells was increased in DA
compared to PVG as assessed by immunohistochemistry
[37]. CD3 was the only T-cell marker used as only a
small number of T cells was expected: a previous FACS
study reported between 0 and 2% CD3+ cells in the
spinal cord (of Sprague–Dawley rats) following injury
[41]. In DA rats, on average 1.4% of the cells in the in-
jured spinal cord were CD3+, in PVG rats 0.8% and
Aplec rats 2.7% (Figure 3A-D), which demonstrates that
the C-type lectin genes affect not only motor neuron
survival but also the degree of T-cell infiltration into the
cord. The above flow-cytometry analysis results are
based on relative numbers of CD3+ cells. In order to ob-
tain a more absolute measure of the number of CD3+
Table 3 The most significantly enriched gene cluster out
of the differentially regulated genes
Transcript ID Gene symbol Gene name
10858573 Clecsf6, Dcir1 C-type (calcium dependent,
carbohydrate recognition domain)
lectin, superfamily member 6
10858559 Clec4a3, Dcir3 C-type lectin domain family 4,
member a3
10865993 Clec2c, Cd69 Cd69 molecule
10880738 Epha8 Eph receptor A8
10858566 Clec4a2, Dcir2 Dendritic cell inhibitory receptor 2
10773298 Mrfap1 Mannosidase 2, alpha B2
10935047 Ngfrap1 Nerve growth factor receptor
(TNFRSF16) associated protein 1
10847156 Olr673 Olfactory receptor 673
10823970 Tlr2 Toll-like receptor 2
10772768 Tlr6 Toll-like receptor 6
10703618 Vom2r21 Vomeronasal 2 receptor, 17;
vomeronasal 2 receptor, 20;
vomeronasal 2 receptor, 18
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cells, we quantified CD3+ cells per acquisition time unit
(see Materials and methods), which showed more CD3+
cells in DA rats compared to PVG rats, but there was
no significant difference between DA and Aplec rats
(Figure 3E). The difference between the analysis methods
can likely be explained by the combined effect from a
proportionally larger T-cell infiltration in Aplec rats and a
slightly higher total cellular yield in the DA rats, caused
by a greater infiltration/expansion of other, not labeled,
cell populations.
CD11b+ cells, which mainly reflect activated microglia
but to a lesser degree also other cell types such as mono-
cytes and macrophages, were also quantified. Around
50% of all cells in the spinal cord were CD11b+ with no
differences between Aplec and DA rats (Figure 3F). The
approximation of the absolute numbers of CD11b+ cells
between the strains did not result in any strain differ-
ences, although there was an insignificant trend for
more CD11b+ cells in DA rats (Figure 3G).
Glial activation is not affected by the Aplec complex
Since glial activation is a prominent feature following
VRA [38] and likely involved in the complex reactions
following injury, this was assessed in DA and Aplec rats
following VRA. Both activation of microglia, assessed by
quantifying CD11b and Mrf-1 expression (Figure 4F,G),
and astrocytes, assessed by quantifying Gfap expression
(Figure 4L), occur in the two strains, but without strain
differences, suggesting that there are no major differ-
ences in the general glial activation pattern between
Aplec and DA rats 5 days after VRA. To further analyze
glial activation, immunolabeling using Gfap and Iba1
was performed, illustrating largely identical staining
patterns between DA and Aplec rats, again suggesting a
similar degree of general glial activation (Figure 4A-E,
H-K).
Aplec genes are expressed by cultured microglia, but not
astrocytes
To study the source of expression of C-type lectins in
the CNS, for which existing information is very limited
and there is a scarcity of commercially available anti-
bodies, expression of all Aplec genes was studied in
naïve and TNF-stimulated astrocytes and microglia de-
rived from DA and PVG rats, respectively (Figure 5A-F).
In general, expression of all genes was barely measurable
Figure 2 Microarray studies of expression of the Aplec complex genes and Cd69 following VRA and the specific characterization of
Cd69 expression in T cells. Microarray expressional profiling of spinal cords from naïve and operated DA and Aplec rats was performed. A
detailed study of all genes in the Aplec segment was performed, as well as of Cd69, a C-type lectin commonly used as a marker of T-cell
activation, as bioinformatical enrichment analysis had revealed differential regulation of Cd69 between the strains. Clecsf6/Dcir1, Clec4a2/Dcir2,
Clec4a3/Dcir3 and Clec4a1/Dcir4 were upregulated following injury in both strains (A-D). Expression of Clec4a3/Dcir3 and Clec4a2/Dcir2 was
higher in Aplec rats and Clecsf6/Dcir1 in DA rats following VRA (A-C). Clec4b2/Dcar1, Clec4d/Mcl and Clec4e/Mincle were not regulated by either
injury or strain (E-G). Cd69, which is not a part of the Aplec complex, was upregulated only in Aplec rats following injury (H). To decide whether
the differential upregulation of Cd69 was caused by inherent T-cell differences, or rather by an increased T-cell influx, characterization of Cd69
expression was performed in naïve and stimulated T cells from DA and Aplec rats. This revealed no significant strain differences in either naïve (I)
or stimulated (J) T cells, suggesting the increased expression in the Aplec spinal cords is derived from an increased number of T cells. VRA: ventral
root avulsion.
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Figure 3 Increased motor neuron survival in the Aplec strain is associated with more prominent T-cell infiltration. Microarray
expressional profiling in Aplec rats suggested involvement of T cells. To confirm this, ipsilateral L3-5 spinal cord segments from DA, PVG and
Aplec rats were analyzed with flow cytometry 5 days after VRA. The relative proportion of CD3+ cells was significantly increased in Aplec rats
compared to both DA and PVG rats (A-D). A-C show representative flow cytometry plots from one animal in each group. To approximate the
absolute number of CD3+ cells in the tissue, the total number of cells acquired/100 seconds was measured in each animal, demonstrating more
CD3+ cells in DA rats compared to PVG rats, but there were no significant differences between DA and Aplec rats suggesting a similar absolute
number of T cells in the strains, but with a relatively larger proportion of T cells in Aplec rats. Also CD11b+ cells were analyzed, revealing around
50% of the cells in the tissue to be CD11b+ with no strain differences (A-C and F), although there was an insignificant trend for DA rats to have
a higher total number of CD11b+ cells (G). Aplec: antigen-presenting lectin-like receptor gene complex; VRA: ventral root avulsion.
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Figure 4 Glial activation is not affected by the Aplec complex. Glial activation is an important feature of the VRA injury response, and
potential differences between DA and Aplec rats following VRA were analyzed. Assessment of microglia activation by RT-PCR quantification of
CD11b and Mrf-1 expression (F,G) and immunolabeling using Iba1 was performed (A-E), illustrating largely identical patterns between DA and
Aplec rats, which suggests a similar degree of microglia activation. Microglia can be seen surrounding the motor neurons, here indicated with
white arrows, which are also easily distinguished by their larger size and more diffusely stained nucleus (D,E). Also astrocyte activation, assessed
by RT-PCR quantification of Gfap expression (L) and immunolabeling (H-K) illustrated similar patterns between the strains. Astrocytes can be seen
surrounding the motor neurons; one motor neuron is marked with a white arrow (J,K). Micrographs B, C, H and I show an overview of the
ipsilateral (IL) ventral horn, whereas A shows the contralateral (CL), healthy side, with clearly less microglial activation. The scale bars correspond
to 40 μm. Aplec: antigen-presenting lectin-like receptor gene complex; CL: contralateral; IL: ipsilateral; RT-PCR: real-time polymerase chain reaction;
VRA: ventral root avulsion.
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in astrocytes and more than 1000-fold higher in micro-
glia. Also, TNF-α stimulation led to upregulation of
Clecsf6, Clec4a1 and Clec4a2 in both strains (Figure 5A,
B,D), but only Clec4a3 in PVG rats (Figure 5C). Thus,
C-type lectins are expressed in microglia but not astro-
cytes and they are upregulated by inflammatory stimuli.
Analysis of M1, M2 and DC markers
Since CLECs are associated with DC levels of CD11c,
expression was assessed in the microarray data to see if
there were any major differences, which may reflect
differences in the DC population. However, the CD11c
levels were low, unaffected by injury, and similar
between the strains arguing against large differences in
DC populations (Figure 6A).
Also macrophages infiltrate the spinal cord after injury,
and it was recently demonstrated that the polarization of
macrophages towards either an M1 (expressing more
iNOS, CD16, CD86 and CD32) or M2 (expressing more
arginase 1, CD206/mannose receptor, CD163, CD14 and
CD23) phenotype affects outcome after spinal cord injury
in mouse [7]. The M1 and M2 phenotypes may also be
relevant in microglia [42]. We therefore assessed expres-
sion levels of most known genes associated with either an
M1 (Figure 6B-E) or M2 (Figure 6F-J) phenotype, and saw
very similar patterns between the strains arguing against a
Figure 5 Aplec genes are expressed by microglia, but not astrocytes, and several are upregulated following inflammatory stimulation.
C-type lectins are mostly known to be expressed by antigen-presenting cells (APCs). In order to determine the source of expression of the Aplec
genes, primary astrocyte and microglia cultures were established from DA and PVG rats and exposed to stimulation with TNF-α. Expression of all
the Aplec genes was more than 1000-fold higher in microglia compared to astrocytes, thus demonstrating that the C-type lectins here studied
are expressed by microglia (A-F). Also, there was strain differences exemplified for instance with upregulation of Clec4a3/Dcir3 only in the PVG
microglia (C), while Clecsf6/Dcir1, Clec4a1/Dcir4, Clec4b2/Dcar1 and Clec4e/Mincle were more highly expressed in microglia derived from DA rats
(A, D-F). Mcl is not shown, but the expression pattern is similar to that of Mincle. APC: antigen-presenting cell; Aplec: antigen-presenting lectin-
like receptor gene complex.
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strong differential polarization towards an M1 or M2
phenotype.
Expression of neurotrophic factors is not affected by the
Aplec complex
There are numerous growth factors that in different
models have proven to exert beneficial effects on motor
neuron survival and development such as neurotrophin-
3 (Ntf3), brain-derived neurotrophic factor (Bdnf) and
glial-derived neurotrophic factor (Gdnf) [43], pleiotrophin
[44], as well as transforming growth factor β2 (Tgfb2)
[45]. Expression levels of these neurotrophic factors did
not differ between DA and Aplec rats in the microarray
data set (Additional file 3: Figure S2A-H). In fact, the
levels of most neurotrophic factors were largely unaffected
by the nerve root injury, except for insulin growth factor 1
(Igf1) and transforming growth factor β1 (Tgfb1), which
were both upregulated after injury, but without differences
between strains (Additional file 3: Figure S2G,H). This
suggests that C-type lectins do not primarily affect motor
neuron survival by influencing the expression of neuro-
trophic factors.
Further fine mapping of the Aplec region
The expression of Clec4a2 and Clec4a3 was higher in
Aplec rats, while Clecsf6 was more expressed in DA rats,
and Clec4a1 did not differ after injury, as demonstrated
both by the microarray and RT-PCR. Dcar1, Mincle and
Mcl were unaffected by VRA. According to the physical
map of the Aplec complex, Clec4a1 is located outside
the Aplec congenic region [19,22] (Figure 7), thus it does
not differ between the Aplec congenic rats and DA rats,
whereas Clec4a2, Clec4a3 and Clecsf6 are within the
congenic region. As Clec4a3 was one of the strongest
expression phenotypesin the F2(DAxPVG) intercross,
the second most differentially regulated gene in micro-
array analysis between DA and Aplec rats and also
differentially regulated in the microglia cultures, it con-
stitutes the most interesting candidate gene, even though
the positive contribution from Clec4a2 in Aplec rats, or
the negative contribution from Clecsf6 in DA rats from
cannot be ruled out.
Discussion
We demonstrate that a genetic variation in a C-type lec-
tin gene cluster (Aplec) occurring among inbred rat
strains significantly affects medium-term neuronal sur-
vival and lymphocyte infiltration following a standard-
ized proximal nerve root avulsion injury.
The function of C-type lectins has mostly been studied
in the context of dendritic cell immunobiology and their
function as antigen-presenting cells, which is relevant
for shaping ensuing adaptive immune responses [46,47].
However, detailed knowledge about the roles of many C-
type lectins is still lacking. Moreover, any possible in-
volvement of CLECs in the reaction to traumatic CNS
Figure 6 Analysis of dendritic cell, M1 and M2 markers displays a similar pattern between DA and Aplec rats. Global expressional
profiling of spinal cords from naïve and operated DA and Aplec rats enabled a detailed study of CD11c, a marker commonly used for dendritic
cells (DCs), as well as markers used to differentiate between M1 (pro-inflammatory) and M2 (anti-inflammatory) macrophages and microglia.
CD11c expression was unaffected by strain or injury, arguing against large differences in DC activity (A). iNOS (inducible NO-synthase), CD16,
CD86 and CD32 are typical M1 markers (B-E) whereas arginase 1, mannose receptor 1/CD206, CD163, CD14 and CD23 are typical M2 markers
(F-J) and they all showed similar patterns without strain differences, where most were significantly upregulated in both DA and Aplec rats after
injury. Aplec: antigen-presenting lectin-like receptor gene complex; DC: dendritic cell’ iNOS: inducible NO-synthase; MR1: mannose receptor 1.
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injuries is entirely unknown. There exist a few examples
where CLECs have been implicated in CNS pathology,
for example, Clec16a has been genetically associated
with susceptibility to multiple sclerosis (MS) [48] and is
upregulated in astrocytes after infectious stimuli [49],
and Clec5a was recently demonstrated to have a disease
regulatory effect in a mouse viral encephalitis model
[50]. Since microglia display certain similarities to DCs
and arguably constitute the main resident APCS in the
CNS [2], it is not surprising that we found a much
higher expression of C-type lectins on microglia com-
pared to astrocytes. The strain differences in CLEC
expression could suggest differential polarization of
microglia in the Aplec and DA strains towards a pheno-
type more like either M1 (inflammatory) or M2 (anti-in-
flammatory). We therefore analyzed the expression of
most known M1 or M2 markers; however, no such dif-
ferences between strains were found. This does not ex-
clude more subtle phenotypic variants not reflected by
differences in the expression of traditional M1/M2 markers,
or that the CLEC expression could be linked to another,
not yet defined, microglia or macrophage subtype.
The CLECs are commonly associated with DCs, which
in the healthy CNS constitute a very small population,
even though they can increase in number in pathological
conditions [51]. These cells may exert effects also in the
context of neurotrauma. For example, injection of DCs
immunized with whole spinal cord homogenate im-
proved outcomes after spinal cord injury in mice [52]
and also higher mammals [53]. However, we did not find
differences in the expression of the DC marker CD11c,
either in naïve animals or after injury. This finding ar-
gues against substantial differences in DC recruitment,
but as for the lack of differences in the expression of
M1/M2 microglia markers, it does not exclude more
subtle differences in the DC activation pattern.
T cells are only rarely encountered in an intact CNS
and infiltration is a tightly regulated process depending
on recruitment/signaling events occurring in the tissue
[54,55]. Thus, for example after a peripheral nerve in-
jury, it is well established that T cells are recruited to the
axotomized motor neuron pools [56], even if the exact
molecular pathways leading to immune cell infiltration
are not entirely understood. Notably, this infiltration
may serve a functionally important purpose as the lack
of immune cells in severe combined immunodeficient
mice has been shown to aggravate the loss of axotomized
cells after facial nerve axotomy [57,58]. This is also highly
relevant for the finding here; namely, that a genetic variabil-
ity in the Aplec cluster not only affects motor neuron sur-
vival, but as an earlier event, also infiltration of T cells to
the cord. This also implies that these molecules are in-
volved not only in regulating processes commonly associ-
ated with strong adaptive immune responses, such as occur
in autoimmune disease models, but also more subtle im-
mune activation patterns occurring in the CNS. Whether
or not increased T-cell infiltration after VRA contributes to
increased motor neuron survival cannot be concluded from
the data presented here. However, accumulating experi-
mental evidence suggests that T cells under some circum-
stances can mediate neuroprotective effects [10], including
chronic models of neurodegeneration [11]. Also, in the
VRA model using the DA strain, concomitant experimental
autoimmune neuroinflammation has been shown to in-
crease the survival of axotomized cells, which was also
associated with the infiltration of large numbers of lympho-
cytes [59]. Interestingly, non-encephalitogenic bystander
recruited T and natural killer (NK) cells were found to ex-
press several neurotrophic factors [59]. We here examined
expression of several neurotrophic factors, including Ntf3,
Bdnf and Gdnf, in the microarray data set without finding
differences in the expression between Aplec and DA rats.
There are also other proposed mechanisms by which T cells
may confer neuroprotection, for example that T cells could
deplete autoreactive/harmful microglia, as NK cells have
been demonstrated to do [60]. However, the lack of differ-
ences between DA and Aplec rats regarding both the ex-
pression of neurotrophic factors and general markers of
microglia activation does not provide support for these two
Figure 7 Genetic architecture of the Aplec segment in detail.
The Aplec gene cluster is a very small segment located between
159.4 and 159.9 Mb of rat chromosome 4, RNO4. The Aplec
congenic strain contains seven genes, all C-type lectins, out of
which the gene D3ZWT9_Rat is poorly characterized, from PVG rats
transferred onto DA background. Aplec: antigen-presenting lectin-
like receptor gene complex.
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proposed mechanisms, at least not in the setting studied
here. Further potential mechanisms could be that T cells
alter the microglia phenotype towards a more protective
M2 phenotype [61] or to a more DC-like profile [11]. The
opposite scenario is also possible, namely, that microglia in-
stead affect the T cells [62], akin to how DCs can modulate
T-cell activation [14,63]. We favor this view in the model
studied here, since microglia activation starts well before T-
cell infiltration following nerve injury [41]. On the other
hand, it is important to acknowledge that the detrimental
effects of T cells for nerve cells is also well established in
many infectious and neuro-inflammatory conditions, such
as EAE [64], and that further research is needed to define
under what conditions T-cell responses may exert positive
or negative effects on nerve cells. It should also be noted
that we have here studied medium-term nerve cell survival
and that differences between strains may level off in the
long-term perspective.
Thus, our results provide strong support for the notion
that the Aplec complex is of importance for communica-
tion between CNS-resident APCs, that is, microglia, and
T cells. Interestingly, the Aplec strain displayed more infil-
trating T cells than both the PVG strain, from which the
Aplec complex derives, and the parental DA strain, which
likely is a result of epistasis, a phenomenon not rarely seen
in congenic rat strains[65,66]. Epistasis implies that there
is a gene-gene interaction between the genes in the
congenic fragment and genes residing in the background
genome where the fragment is integrated. Due to the lim-
ited information available on binding partners for specific
C-type lectins it is difficult to speculate on candidates for
this effect, especially since this may not only depend on
differences in expression but alsoon genetic variations af-
fecting protein structure. Nevertheless, this is important
to bear in mind when interpreting the large amount of
seemingly disparate results concerning the effect of T cells
and microglia in different experimental models, since the
genetic set-up of the experimental animal will affect mul-
tiple cellular processes, which may be further amplified
when studying complex in vivo reactions involving mul-
tiple cell types.
The CLEC family is complex; there are 25 rat paralogs
to Clec4a3, out of which Clecsf6 (Dcir1), Clec4a2
(Dcir2), Clec4b2 (Dcar) and Clec4a1 (Dcir4) are clearly
the most similar; all are located in the Aplec cluster and
display around 50% sequence homology both at cDNA
and protein level [25] with each other. Also, the above
mentioned four CLECs are orthologs to human Clec4a
(Dcir), which has been shown to be expressed mostly on
DCs and assigned a role for modulating and shaping T-
cell and general immune responses [63,67]. The mouse
ortholog to Dcir has been functionally studied using
Dcir−/− mice, which displayed increased susceptibility to
various autoimmune conditions characterized by excessive
expansion of the DC pool [68]. Our findings are thus con-
cordant with previous knowledge regarding CLECs, and
especially Dcir and its rat homologs, suggesting that the
genes act through APCs, in our case microglia, to regulate
immune, and specifically T-cell responses. Due to the
complex architecture of the gene family in both rats and
mice, it is difficult to dissect the role of one gene from an-
other; however, the eQTL mapping data from the F2
(DAxPVG) intercross identifies Clec4a3 as a very interest-
ing candidate for further studies. This could be done with
extensive breeding to create sub-congenic strains, even if
this may be very time consuming, or the creation of trans-
genic animals, which is now also possible for rats.
Conclusions
We here demonstrate that a genetic variation occurring
between inbred DA and PVG rats in the Aplec cluster,
which encodes six characterized C-type lectin genes, sig-
nificantly affects survival of axotomized motor neurons
and T-cell infiltration after nerve root injury. Through
extensive global expression profiling in an intercross
between DA and PVG rats, one of the Aplec genes,
Clec4a3 (Dcir3), was identified as one of the strongest
cis-regulated eQTLs, thus, identifying it as a strong can-
didate to mediate the congenic phenotype. The function
of Clec4a3 is still poorly studied, but in a small study it
was found to have immunoregulatory functions in mac-
rophages in vitro [69]. The finding of expression of the
relevant C-type lectin transcripts in microglia suggests
that they play an important role for recruiting/priming
T cells. These results provide strong support for the no-
tion that CLECs are important not only for shaping
adaptive antigen-restricted immune responses occurring
at a systemic level, but also localized inflammatory reac-
tions occurring after nerve root injury and that this af-
fects medium-term nerve cell survival. A more detailed
characterization over time of the cellular and molecular
processes that occur after VRA and how this is affected
by the Aplec region is needed to provide a better under-
standing of underlying mechanisms. Also, further studies
aimed at defining the ligands binding to C-type lectins
and clarification of how signaling through C-type lectins
prime APCs and shapes subsequent T-cell responses are
warranted to clarify their role in basic neuroimmune
interactions occurring both in primarily autoimmune
neuroinflammation and conditions with inflammatory
components, such as traumatic nerve injuries.
Additional files
Additional file 1: Table S1. List of differentially regulated genes (P <
0.01) between DA and Aplec rats, and between naïve and injured Aplec
rats. The table shows the genes differentially expressed between DA and
Aplec rats following VRA.
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Additional file 2: Figure S1. RT-PCR confirmation of the expression of
the Aplec genes and Cd69. To confirm the results from the microarray
expressional profiling of the DA and Aplec spinal cords, RT-PCR analysis
of expression in the L3 segments from naïve and VRA operated animals
from both strains was performed. The RT-PCR quantification confirmed
the microarray results; Clecsf6 (Dcir1), Clec4a2 (Dcir2), Clec4a3 (Dcir3) and
Clec4a1(Dcir4), were all upregulated following injury in both strains, but
with higher expression of Clec4a2 and Clec4a3 in Aplec and of Clecsf6 in
DA and no strain differences in Clec4a1 (A-D). Dcar showed no injury or
strain variation (E). Cd69 was significantly upregulated only in the Aplec
strain (F).
Additional file 3: Figure S2. Expression of neurotrophic factors in DA
and Aplec rats. Expression of the most acknowledged factors with
neurotrophic effects was assessed in the microarray expressional profiling
data set. Expression of (A) neurotrophin-3 (Ntf3), (B) brain-derived
neurotrophic factor (Bdnf), (C) glial-derived neurotrophic factor (Gdnf),
(D) nerve growth factor (Ngf), (E) pleiotrophin and (F) transforming
growth factor β2 (Tgfb2), was regulated by neither injury nor strain. In
contrast, the expression of (G) transforming growth factor β1 (Tgfb1) and
(H) insulin growth factor 1 (Igf1) was upregulated in both strains, but
without differences.
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